PTHS · Pelthos Therapeutics Inc. · Investor Relations
$20.71
+0.36 (+1.77%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“in prior periods, management disclosed substantial doubt about the Company's ability to continue as a going concern. The conditions and events that previously raised substantial doubt have been alleviated by management's plans and actions.”View the 10-Q filed May 14, 2026
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 2
16.81K
Avg daily vol (3M)
58.45K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-29 | 2026 Annual Meeting of Shareholders | Shareholder meeting |
| 2026-08-13 | Second Quarter 2026 Financial Results Call | Earnings call |
| 2026-06-04 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-05-14 | First Quarter 2026 Financial Results Call | Earnings call |
| 2026-03-19 | Fourth Quarter and Full Year 2025 Financial Results Call | Earnings call |
Source: https://ir.pelthos.com/